Real Research

Executive Summary

Real Research is a Polish biotechnology company leveraging AI to transform clinical research and patient recruitment, while also developing LifeGel, a proprietary 3D cell culture technology. Founded in 2018 and headquartered in Warsaw, the company operates at the intersection of digital health and AI/ML, aiming to accelerate drug development and improve preclinical models. Its dual focus positions it to address inefficiencies in patient enrollment and the limitations of traditional 2D cell cultures. The AI platform uses machine learning to match patients with suitable clinical trials, potentially reducing recruitment time and costs. Meanwhile, LifeGel provides a more physiologically relevant environment for drug testing, which could enhance predictivity and reduce reliance on animal models. Although the company is still at an early stage with limited public traction, its integrated approach could appeal to pharmaceutical partners seeking to modernize their R&D pipelines.

Upcoming Catalysts (preview)

• Q4 2026Pharmaceutical partnership for AI patient recruitment platform35% success
• Q2 2027Publication of validation data for LifeGel in a peer-reviewed journal50% success
• Q1 2027Completion of Series A funding round40% success